Chemistry Letters Vol.34, No.7 (2005)
1023
Table 1. Preparation of compounds 4 or 5
2
3
L. Santana, M. Teijeira, E. Uriarte, J. Balzarini, and E. De
Clercq, Eur. J. Med. Chem., 37, 755 (2002).
J. M. Blanco, O. Caamano, F. Fernandez, X. Garcia-Mera,
A. R. Hergueta, C. Lopez, J. E. Rodriguez-Borges, J.
Balzarini, and E. De Clerco, Chem. Pharm. Bull., 47, 1314
(1999).
M. I. Nieto, O. Caamano, F. Fernandez, M. Gomez, J.
Balzarini, and E. De Clercq, Nucleosides Nucleotides, 21,
243 (2002).
Yield
/%a
Ar1
Ar2
R
4a
4b
4c
4d
4e
4f
4g
4h
4i
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Et
n-Pr
n-Bu
PhCH2
i-Pr
85
88
76
84
80
78
83
81
74
81
90
82
87
76
83
4
cyclohexyl
i-Pr
5
6
W. A. Slusarchyk and R. Zahler, U. S. Patent 5723609
(1988); Chem. Abstr., 128, 230636c (1998).
4-ClC6H4
4-ClC6H4
4-ClC6H4
4-ClC6H4
4-ClC6H4
Ph
Ph
4-ClC6H4
4-ClC6H4
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Et
t-Bu
i-Pr
cyclohexyl
H
CH3
H
CH3
E. Matthes, M. Von Janta-Lipinski, K. Reimer, W. Mueller,
H. Meisel, C. Lehmann, and J. Schildt, Eur. Patent 409227
(1991); Chem. Abstr., 115, 159680m (1991).
F. E. Nielsen, E. B. Pedersen, and M. Begtrup, Liebigs Ann.
Chem., 1984, 1848.
M. Nogueras, M. Melguizo, M. L. Quijano, and A. Sanchez,
J. Heterocycl. Chem., 28, 1417 (1991).
A. R. Asenjo, S. M. Melgarejo, M. M. Noqueras, A. M.
Rodriquez, M. C. Rodriquez, and R. A. Sanchez, Nucleo-
sides Nucleotides, 3, 207 (1984).
4j
4k
5a
5b
5c
5d
7
8
9
aIsolated yields based on iminophosphorane 1.
10 W. Ried, R. Guryn, and J. Laoutidis, Liebigs Ann. Chem.,
1990, 819.
11 P. Scheiner, S. Arwin, M. Eliacin, and J. Tu, J. Heterocycl.
Chem., 22, 1435 (1985).
12 M. L. Sznaidman and L. M. Beauchamp, J. Heterocycl.
Chem., 33, 1605 (1996).
13 F. Chretien and B. Gross, Tetrahedron, 38, 103 (1982).
14 a) M. W. Ding, S. Z. Xu, and J. F. Zhao, J. Org. Chem., 69,
8366 (2004). b) M. W. Ding, Y. F. Chen, and N. Y. Huang,
Eur. J. Org. Chem., 2004, 3872. c) M. W. Ding, S. J. Yang,
and J. Zhu, Synthesis, 2004, 75. d) M. W. Ding, G. P. Zeng,
and T. J. Wu, Synth. Commun., 30, 1599 (2000). e) M. W.
Ding, Y. Sun, X. P. Liu, and Z. J. Liu, Org. Prep. Proced.
Int., 35, 391 (2003).
15 a) M. D. Chen, G. P. Yuan, and S. Y. Yang, Chin. J. Org.
Chem., 20, 357 (2000). b) M. Chen, G. Yuan, and S. Yang,
Synth. Commun., 30, 1287 (2000). c) M. Chen, Y. Zheng,
G. Gao, S. Fan, and S. Lu, Heterocycl. Commun., 9, 395
(2003).
carbodiimide 2. It is deduced that the intermediate 3 has gener-
ated but cyclizes quickly and the catalysis by sodium ethoxide
is not needed (Scheme 2). The reversed-selective formation of
5 can be rationalized in terms of a direct cyclization of the
guanidine intermediate 3 to give 5 across the little steric and
strong nucleophilic amino or methylamino group rather than
the arylamino one.
It is worth noting that the selectivity of the reaction between
ꢀ- or ꢁ-ethoxycarbonyl carbodiimide and amine seems to be
controversial. Sometimes the alkylamino substituted heterocycle
was isolated as the major or sole product,17,18 whereas the aryla-
mino substituted heterocycle was produced as the sole product
in other cases.19 The results we report here reveal firstly that
the different selectivity is probably due to the different reaction
condition (in the presence or absence of a base catalyst) and then
different reaction mechanism (base catalytic cyclization mecha-
nism or direct cyclization mechanism).
In conclusion, we have developed an efficient and selective
synthesis of 7H-1,2,3-triazolo[4,5-d]pyrimidin-7-ones via the
aza-Wittig reaction. Owing to the mild reaction conditions, good
yields, easily accessible starting materials and straightforward
product isolation, we think that the versatile synthetic approach
discussed here in many cases compares favorably with other
existing methods.
16 H. Wamhoff and G. Haffmanns, Chem. Ber., 117, 585
(1984).
17 a) M. W. Ding, Y. Sun, X. P. Liu, and Z. J. Liu, Chin. J.
Chem., 21, 577 (2003). b) Y. Liang, M. W. Ding, Z. J. Liu,
and X. P. Liu, Synth. Commun., 33, 2843 (2003). c) M. W.
Ding, Z. F. Xu, Z. J. Liu, and T. J. Wu, Synth. Commun.,
31, 1053 (2001).
We gratefully acknowledge financial support of this work by
the National Basic Research Program of China (2003CB114400)
and the National Natural Science Foundation of China (Project
Nos. 20372023 and 20102001).
18 a) P. Molina, P. M. Fresneda, and P. Almendros, Tetrahe-
dron Lett., 33, 4491 (1992). b) P. Molina, P. Almendros,
and P. M. Fresneda, Tetrahedron, 50, 2241 (1994). c) T.
Saito, K. Tsuda, and Y. Saito, Tetrahedron Lett., 37, 209
(1996). d) D. V. Vilarelle, C. P. Veira, and J. M. Q. Lopez,
Tetrahedron, 60, 275 (2004).
References
1
K. A. Jacobson, J. W. Daly, and V. Manganiello, ‘‘Purines
in Cellular Signaling: Targets for New Drugs,’’ Spinger-
Verlag, New York (1990).
19 a) E. C. Taylor and M. Patel, J. Heterocycl. Chem., 28, 1857
(1991). b) M. Watanabe, H. Okada, T. Teshima, M. Noguchi,
and A. Kakehi, Tetrahedron, 52, 2827 (1996).
Published on the web (Advance View) June 18, 2005; DOI 10.1246/cl.2005.1022